semaglutide side effects depression and Benefits Psychiatric adverse events associated with

Tara *Based on internal survey 416 GLP-1 users in 2025 **Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss within the WW Clinic Program and participating in the GLP-1 companion nutrition program

Gomisin N attenuated cerebral ischemia-reperfusion injury through inhibition of autophagy by activating the PI3K/AKT/mTOR pathway

Hershey 2007)

The Salt Lake City metropolitan area has an adult obesity rate of 27%, and demand for GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound) continues to grow